Your perspective can help contribute to a better understanding of GATA2 deficiency and support more personalised care.
📅 Survey closes: 31 October 2026
👉 Take the survey: www.surveymonkey.com/r/V7B9F83
🔗 Learn more: gata2project.eu
Your perspective can help contribute to a better understanding of GATA2 deficiency and support more personalised care.
📅 Survey closes: 31 October 2026
👉 Take the survey: www.surveymonkey.com/r/V7B9F83
🔗 Learn more: gata2project.eu
Across 507 TCGA-UCEC and 230 CPTAC-UCEC tumours, GATA2 and SOX9 retained direction across cohorts, but neither passed the universal single-target-deletion gate.
doi.org/10.5281/zeno...
Across 507 TCGA-UCEC and 230 CPTAC-UCEC tumours, GATA2 and SOX9 retained direction across cohorts, but neither passed the universal single-target-deletion gate.
doi.org/10.5281/zeno...
Biallelic CEBPA 合併 GATA2 突變仍維持 favorable —— 這是少數不會拉低預後的共突變。
其餘都往壞的方向走:NPM1 加 DNMT3A、CEBPA 加 WT1、t(8;21) 加 KIT。
記法:壞朋友一堆,好朋友只有 GATA2。
#血液專科
https://hema-2026.hsiehting.com/q/110-019
Biallelic CEBPA 合併 GATA2 突變仍維持 favorable —— 這是少數不會拉低預後的共突變。
其餘都往壞的方向走:NPM1 加 DNMT3A、CEBPA 加 WT1、t(8;21) 加 KIT。
記法:壞朋友一堆,好朋友只有 GATA2。
#血液專科
https://hema-2026.hsiehting.com/q/110-019
Diamond-Blackfan anemia —— 白血球與血小板生成正常,只有紅血球前驅細胞在 proerythroblast 階段被阻斷。
Fanconi anemia、dyskeratosis congenita、Shwachman-Diamond、GATA2 症候群則多隨病程進展為三系全血球低下。
記法:Diamond-Blackfan 只有紅血球倒下。
#血液專科
https://hema-2026.hsiehting.com/q/111-054
Diamond-Blackfan anemia —— 白血球與血小板生成正常,只有紅血球前驅細胞在 proerythroblast 階段被阻斷。
Fanconi anemia、dyskeratosis congenita、Shwachman-Diamond、GATA2 症候群則多隨病程進展為三系全血球低下。
記法:Diamond-Blackfan 只有紅血球倒下。
#血液專科
https://hema-2026.hsiehting.com/q/111-054
ZEB1 guides KLF1 into the cell’s heart to find maturity, turning fragile beginnings into the red cells that sustain our every breath.
academic.oup.com/nar/article/...
ZEB1 guides KLF1 into the cell’s heart to find maturity, turning fragile beginnings into the red cells that sustain our every breath.
academic.oup.com/nar/article/...
A. GATA1
B. GATA2
C. RUNX1
D. CEBPA
A. GATA1
B. GATA2
C. RUNX1
D. CEBPA
A. GATA1
B. GATA2
C. RUNX1
D. CEBPA
Type your answer in the chat and come back next week for the answer and explination!
A. GATA1
B. GATA2
C. RUNX1
D. CEBPA
Type your answer in the chat and come back next week for the answer and explination!
A. ANKRD26
B. GATA2
C. CEBPA
D. DDX41
A. ANKRD26
B. GATA2
C. CEBPA
D. DDX41
A. ANKRD26
B. GATA2
C. CEBPA
D. DDX41
Type your answer in the chat below and come back next week for the answer and explanation!
A. ANKRD26
B. GATA2
C. CEBPA
D. DDX41
Type your answer in the chat below and come back next week for the answer and explanation!
https://research-er.jp/articles/view/155790
https://research-er.jp/articles/view/155790
Read more ➡️ www.onclive.com/view/gata2-g...
#Leukemia #MDS #oncology
Read more ➡️ www.onclive.com/view/gata2-g...
#Leukemia #MDS #oncology